A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

NCT01412060 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

765

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Placebo
DRUG: Cariprazine

Sponsor

Forest Laboratories

Collaborators

[object Object]